Stockreport

Juno Therapeutics Reports Third Quarter 2017 Financial Results

JUNO THERAPEUTICS  (JUNO) 
Last juno therapeutics earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.junotherapeutics.com/investor-relations
PDF - TRANSCEND pivotal trial ongoing using dose level 2 - - Promising data with JCAR017 in DLBCL at dose level 2: 80% (12/15) ORR and 73% (11/15) CR [Read more]